Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11411-11418
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11411
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11411
Characteristic | Seropositivity |
No therapy | 94.1% (43/51) |
Targeted therapy | 83.3% (30/36) |
Immunotherapy | 74.1% (20/27) |
Chemotherapy | 66.7% (12/18) |
- Citation: Cai SW, Chen JY, Wan R, Pan DJ, Yang WL, Zhou RG. Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China. World J Clin Cases 2022; 10(31): 11411-11418
- URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11411.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11411